Abstract
Introduction
Misoprostol, a prostaglandin derivative, reduces blood flow to uterus, facilitating every surgical operation on myometrium.
Method
PubMed, Scopus and Cochrane databases were systematically searched and five studies met the inclusion criteria for our meta-analysis.
Results
In total, 283 patients were included. The intention to treat population included 142 patients. The mean age of the patients was 34 years old. The vaginal route of administration was preferred in 117 out of 142 patients and the rectal route in 25 patients. Three studies were included in the analysis regarding duration of operation, estimated blood loss, preoperative/postoperative hemoglobin, transfusions needed and febrile morbidity. No significant difference was observed between vaginal suppository and placebo group concerning the duration of operation, the fall of preoperative hemoglobin, transfusions needed and the febrile morbidity. Regarding the estimated blood loss, the mean difference observed between the misoprostol and placebo groups was −148.55 mL per operation (95 % CI, −233.10 to −64), p < 0.001. As far as the postoperative Hgb, the misoprostol group presented significantly smaller reduction, 0.68 gr/dL per operation (95 % CI, 0.38–0.97), p < 0.001.
Conclusion
Easy to use, minor or no side effects, and good clinical outcomes are the properties that render misoprostol useful in the realization myomectomy independently of the surgical technique applied.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tang OS, Gemzell-Danielsson K, Ho PC (2007) Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 99(Suppl 2):S160–S167
Choksuchat C (2010) Clinical use of misoprostol in nonpregnant women: review article. J Minim Invasive Gynecol 17:449–455
Goldberg AB, Carusi DA, Meckstroth KR (2003) Misoprostol in gynecology. Curr Womens Health Rep 3:475–483
Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J (2005) Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 112:547–553
Brown SE, Toner JP, Schnorr JA et al (2001) Vaginal misoprostol enhances intrauterine insemination. Hum Reprod 16:96–101
Kongnyuy EJ, Wiysonge CS (2014) Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 8:CD005355
Yip SK, Tse AO, Haines CJ, Chung TK (2000) Misoprostol’s effect on uterine arterial blood flow and fetal heart rate in early pregnancy. Obstet Gynecol 95:232–235
Celik H, Sapmaz E (2003) Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril 79:1207–1210
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Moher D, Pham B, Jones A et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609–613
Niroomand N, Hajiha S, Tabrizi NM, Ghajarzadeh M. A single dose of misoprostol for reducing hemorrhage during myomectomy: a randomized clinical trial. Arch Gynecol Obstet 2015
Ragab A, Khaiary M, Badawy A (2014) The Use of single versus double dose of intra-vaginal prostaglandin E2 “misoprostol” prior to abdominal myomectomy: a randomized controlled clinical trial. J Reprod Infertil 15:152–156
Frederick S, Frederick J, Fletcher H, Reid M, Hardie M, Gardner W (2013) A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy. Fertil Steril 100:1044–1049
Kalogiannidis I, Xiromeritis P, Prapas N, Prapas Y (2011) Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial. Clin Exp Obstet Gynecol 38:46–49
Agostini A, Ronda I, Franchi F et al (2005) Oxytocin during myomectomy: a randomized study. Eur J Obstet Gynecol Reprod Biol 118:235–238
Ikechebelu JI, Ezeama CO, Obiechina NJ (2010) The use of torniquet to reduce blood loss at myomectomy. Niger J Clin Pract 13:154–158
Shokeir T, Shalaby H, Nabil H, Barakat R (2013) Reducing blood loss at abdominal myomectomy with preoperative use of dinoprostone intravaginal suppository: a randomized placebo-controlled pilot study. Eur J Obstet Gynecol Reprod Biol 166:61–64
Vercellino G, Erdemoglu E, Joe A et al (2012) Laparoscopic temporary clipping of uterine artery during laparoscopic myomectomy. Arch Gynecol Obstet 286:1181–1186
Benassi L, Lopopolo G, Pazzoni F et al (2000) Chemically assisted dissection of tissues: an interesting support in abdominal myomectomy. J Am Coll Surg 191:65–69
Lumsden MA (2002) Embolization versus myomectomy versus hysterectomy: which is best, when? Hum Reprod 17:253–259
Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z (2014) Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2:CD003249
Law KS, Abbott JA, Lyons SD (2014) Energy sources for gynecologic laparoscopic surgery: a review of the literature. Obstet Gynecol Surv 69:763–776
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iavazzo, C., Mamais, I. & Gkegkes, I.D. Use of misoprostol in myomectomy: a systematic review and meta-analysis. Arch Gynecol Obstet 292, 1185–1191 (2015). https://doi.org/10.1007/s00404-015-3779-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3779-x